Godolphin Resources Limited (ASX: GRL) Achieves Major Milestone in Rare Earth Project
Godolphin Resources (ASX: GRL) successfully produces MREC-2, advancing the Narraburra Project and preparing for future industry engagements.

Godolphin Resources (ASX: GRL) successfully produces MREC-2, advancing the Narraburra Project and preparing for future industry engagements.
LTR Pharma Limited secures A$25 million to advance its SPONTAN® treatment through regulatory processes in the U.S. market.
Transurban Group (ASX:TCL) declares a 32.0-cent distribution and reaffirms its FY25 guidance amidst notable traffic growth.
Develop Global Limited finalises a loan facility with Trafigura and is progressing towards the re-start of the Woodlawn Copper-Zinc Mine.
Terrain Minerals Limited has commenced drilling at its Wildflower Gold Project, aiming to explore newly identified mineral zones.
AUCyber Limited addresses ASX inquiries regarding a revenue shortfall and the withdrawal of FY25 guidance.
Novatti Group Limited (ASX:NOV) completes capital raising, securing $2 million to drive growth strategies and enhance financial performance.
Strata Minerals Limited (ASX:SMX) announces major advancements in gold, uranium, and rare earths exploration projects.
Acrow Limited (ASX:ACF) secures a $42 million contract for the Project Ceres Urea Plant, marking a major milestone in the company’s growth.
Recce Pharmaceuticals receives approval for a Phase 3 trial of RECCE® 327 in Indonesia for diabetic foot infections.